These EVs also carry immunosuppressive molecules, including PD-L1, TGF-β, and IL-10, which inhibit T cell activation or promote components of immune suppressive TME, such as Tregs and MDSCs, further dampening anti-tumor immunity (83, 84). The gene discussed is TGFB1; the disease is neoplasm.